Silverfin false false 31/08/2025 01/09/2024 31/08/2025 S Ball 08/09/2020 14 May 2026 The principal activity of the company is that of a holding company. 12864571 2025-08-31 12864571 bus:Director1 2025-08-31 12864571 2024-08-31 12864571 core:CurrentFinancialInstruments 2025-08-31 12864571 core:CurrentFinancialInstruments 2024-08-31 12864571 core:ShareCapital 2025-08-31 12864571 core:ShareCapital 2024-08-31 12864571 core:RetainedEarningsAccumulatedLosses 2025-08-31 12864571 core:RetainedEarningsAccumulatedLosses 2024-08-31 12864571 core:CostValuation 2024-08-31 12864571 core:CostValuation 2025-08-31 12864571 bus:OrdinaryShareClass1 2025-08-31 12864571 2024-09-01 2025-08-31 12864571 bus:FilletedAccounts 2024-09-01 2025-08-31 12864571 bus:SmallEntities 2024-09-01 2025-08-31 12864571 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 12864571 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12864571 bus:Director1 2024-09-01 2025-08-31 12864571 2023-09-01 2024-08-31 12864571 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 12864571 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12864571 (England and Wales)

SSJB FUSION LIMITED

Unaudited Financial Statements
For the financial year ended 31 August 2025
Pages for filing with the registrar

SSJB FUSION LIMITED

Unaudited Financial Statements

For the financial year ended 31 August 2025

Contents

SSJB FUSION LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 August 2025
SSJB FUSION LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 August 2025
Note 2025 2024
£ £
Fixed assets
Investments 3 1 1
1 1
Current assets
Debtors 4 10 10
Cash at bank and in hand 30,064 30,064
30,074 30,074
Creditors: amounts falling due within one year 5 ( 7,078) ( 7,078)
Net current assets 22,996 22,996
Total assets less current liabilities 22,997 22,997
Net assets 22,997 22,997
Capital and reserves
Called-up share capital 6 10 10
Profit and loss account 22,987 22,987
Total shareholder's funds 22,997 22,997

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of SSJB Fusion Limited (registered number: 12864571) were approved and authorised for issue by the Director. They were signed on its behalf by:

S Ball
Director

14 May 2026

SSJB FUSION LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2025
SSJB FUSION LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

SSJB Fusion Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 35 Ballards Lane, London, N3 1XW, United Kingdom.

The principal activity of the company is that of a holding company.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets
Basic financial assets, including other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including other creditors, and amounts owed to director are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the company during the year, including the director 1 1

3. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 September 2024 1 1
At 31 August 2025 1 1
Carrying value at 31 August 2025 1 1
Carrying value at 31 August 2024 1 1

4. Debtors

2025 2024
£ £
Other debtors 10 10

5. Creditors: amounts falling due within one year

2025 2024
£ £
Other creditors 7,078 7,078

6. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
10 Ordinary shares of £ 1.00 each 10 10